HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant human interferon gamma therapy for osteopetrosis.

Abstract
A defect in leukocytic superoxide formation has been demonstrated in patients with congenital osteopetrosis. This leukocyte defect appears to be related to defective bone resorption. Because recombinant human interferon gamma therapy enhances superoxide production in patients with chronic granulomatous disease, we sought to determine whether a similar strategy could reverse the osteopetrotic condition. Interferon gamma, 1.5 micrograms/kg three times a week, was administered by subcutaneous injection for 6 months to eight patients with osteopetrosis. Urinary hydroxyproline and urinary calcium excretion increased markedly during therapy in parallel with a significant decrease in trabecular bone volume. Bone marrow scans demonstrated increased bone marrow production. The hemoglobin concentration, platelet count, and leukocyte production of superoxide increased significantly. No serious infections were encountered during the therapy. These data suggest that interferon gamma administration enhances bone resorption and leukocyte function in patients with osteopetrosis.
AuthorsL L Key Jr, W L Ries, R M Rodriguiz, H C Hatcher
JournalThe Journal of pediatrics (J Pediatr) Vol. 121 Issue 1 Pg. 119-24 (Jul 1992) ISSN: 0022-3476 [Print] United States
PMID1320672 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Calcium, Dietary
  • Hemoglobins
  • Recombinant Proteins
  • Superoxides
  • Interferon-gamma
  • Hydroxyproline
  • Calcium
Topics
  • Bone Marrow (pathology)
  • Bone Resorption (metabolism)
  • Bone and Bones (metabolism, pathology)
  • Calcium (urine)
  • Calcium, Dietary (administration & dosage)
  • Child
  • Child, Preschool
  • Hearing (physiology)
  • Hemoglobins (analysis)
  • Humans
  • Hydroxyproline (urine)
  • Infant
  • Injections, Subcutaneous
  • Interferon-gamma (administration & dosage, adverse effects, therapeutic use)
  • Osteoclasts (pathology)
  • Osteopetrosis (pathology, therapy, urine)
  • Platelet Count
  • Recombinant Proteins
  • Superoxides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: